Inventor · disambiguated record
Howard R. Heyman
Also filed as: HEYMAN HOWARD R · HEYMAN HOWARD ROBIN · HEYMAN Howard
15 granted patents·13 pending applications·197 citations·filing 2000–2017
92Inventor score
Top patents by PatentIndex Score
28 records- 0197US6294573B1Reverse hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 2000·Granted Sep 25, 2001·131 cites·17 claims
- 0292US9464082B2Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsABBVIE INC·Filed 2015·Granted Oct 11, 2016·18 cites·24 claims
- 0390US8975398B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Mar 10, 2015·13 cites·13 claims
- 0483US9187472B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 17, 2015·5 cites·1 claims
- 0582US7202363B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2004·Granted Apr 10, 2007·12 cites·9 claims
- 0676US9193723B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 24, 2015·2 cites·18 claims
- 0776US8426408B2Pyrimidine inhibitors of kinasesCURTIN MICHAEL·Filed 2010·Granted Apr 23, 2013·7 cites·14 claims
- 0874US9296723B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·1 cites·8 claims
- 0973US9302989B2NAMPT and rock inhibitorsCURTIN MICHAEL L·Filed 2011·Granted Apr 5, 2016·4 cites·20 claims
- 1070US7737160B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2007·Granted Jun 15, 2010·2 cites·16 claims
- 1169US8273736B2Thienopyridine and furopyridine kinase inhibitorsBETSCHMANN PATRICK·Filed 2009·Granted Sep 25, 2012·1 cites·14 claims
- 1269US2010076051A1Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2009·Application pending·0 cites
- 1361US7129260B2Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2004·Granted Oct 31, 2006·1 cites·15 claims
- 1456US10053474B2Anti-viral compoundsABBVIE INC·Filed 2017·Granted Aug 21, 2018·0 cites·17 claims
- 1555US9758511B2NAMPT inhibitorsABBVIE INC·Filed 2016·Granted Sep 12, 2017·0 cites·7 claims
- 1652US2016184281A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 1752US2017065575A1Nampt inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 1852US2017135994A9Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 1951US2006287370A1Isoindolinone kinase inhibitorsCURTIN MICHAEL L·Filed 2006·Application pending·0 cites
- 2047US2015141398A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 2144US2005026944A1Thienopyridine and furopyridine kinase inhibitorsFiled 2004·Application pending·0 cites
- 2241US2005020619A1Thienopyridine kinase inhibitorsFiled 2003·Application pending·0 cites
- 2339US10093624B2NAMPT and ROCK inhibitorsABBVIE INC·Filed 2015·Granted Oct 9, 2018·0 cites·18 claims
- 2439US2002177594A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
- 2539US2019358214A1Compositions and Methods for Treating HCV InfectionABBVIE INC·Filed 2017·Application pending·0 cites
- 2635US2002103192A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
- 2733US2011275630A1Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2010·Application pending·0 cites
- 2829US2012122924A1Nampt inhibitorsCURTIN MICHAEL L·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Howard R. Heyman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →